10 October 2024
10 October 2024
The deal allows MSD to license one or more therapies against inflammatory diseases developed using the UK biotech’s fibroblast platform.
In conjunction with the funding announcement, Arda has appointed Scott Turner as its new chief scientific officer.
The regulator sought additional analyses from existing continuous glucose monitoring data collected during Phase III trials.
Circle is entitled to upfront and milestone payments up to $607m.
The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.
Purespring Therapeutics has raised $105m in a Series B funding round which will help progress its lead candidate PS-002 to clinic.
Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.
As a major report highlights the challenges of a struggling NHS, the call for preventative care is growing in the UK. With a taskforce investigating ways of integrating preventative health services into communities, and a powerful case finding solution now available to put proactive care into action, we explore the latest in preventative health innovation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
